|
PF-57911 |
PREGABALINA Remus 75 mg Tabletas |
2025-02-11 |
|
Remus Pharmaceuticals PVT.LTD. |
India
|
Seven Pharma Guatemala |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-57988 |
TIGECICLINA Remus 50 mg polvo para uso parenteral |
2025-02-27 |
|
Remus Pharmaceuticals PVT.LTD. |
India
|
Arael de Centro América |
Novoswiss Pharmaceuticals |
Medwell International |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-59005 |
OFLOXACINA Remus 400 mg Tabletas recubiertas con película |
2026-02-09 |
|
Remus Pharmaceuticals PVT.LTD. |
India
|
Seven Pharma Guatemala |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-57449 |
SPRAVATO 28 mg Solucion en aerosol nasal |
2024-11-07 |
|
Ethnor del Istmo, S. A. |
Estados Unidos de América
|
J.I.Cohen, S.A. |
Agencias J. I. Cohen |
Centro Distribuidor, Sociedad Anónima |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-53357 |
VITAMINA E Epicon 1000 UI Cápsulas de gelatina blanda |
2021-10-06 |
|
Epicon |
India
|
Ladi |
Epicon |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PFD-53739 |
VITAMINA E Epicon 400 UI Cápsulas de gelatina blanda |
2022-03-02 |
|
Epicon |
India
|
Epicon |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-54099 |
DICLOFENACO 50 mg + NEUROTROPAS , Renown Pharmaceuticals, cápsulas de gelatina blanda. |
2022-06-05 |
|
Renown Pharmaceuticals Pvt. Ltd. |
India
|
Epicon |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-45636 |
KETAL DUO Solución Inyectable |
2016-02-21 |
|
Schering Plough S.A.de C.V. |
Mexico
|
Amicelco |
Agencias J.I. Cohen |
Droguería Colón |
Refasa |
Merigal |
Droguería Y Farmacia Lanquetin |
Bodega Farmacéutica, S.A. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-47601 |
KETAL DUO 10 mg / 25 mg Cápsulas |
2017-07-23 |
|
Schering Plough S.A.de C.V. |
Mexico
|
Amicelco |
Agencias J.I. Cohen |
Droguería Colón |
Refasa |
Merigal |
Droguería Y Farmacia Lanquetin |
Bodega Farmacéutica, S.A. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-26531 |
Bencilpenicilina Sodica Cristalina Rimsa 1000000 UI polvo para inyecci |
2006-09-26 |
|
Representaciones E Investigaciones Medicas S.A. De C.V. |
Mexico
|
Servi-hospitales |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|